Conference Coverage

MicroRNAs flag liver damage in HIV-, HCV-infected persons


 

REPORTING FROM CROI

BOSTON – In persons infected with HIV-1, with or without hepatitis C coinfections, specific circulating microRNAs may signal the presence of liver injury and progression, investigators stated.

An analysis of small RNA expression in plasma samples from 144 HIV-infected patients showed that two microRNAs (miRNAs) in the same family of RNA fragments were significantly upregulated in patients with HIV-1 and HCV coinfections that progressed to liver cirrhosis, despite the patients having no evidence of liver fibrosis at the time of plasma sampling, reported Miguel Angel Martinez, PhD, of IrsiCaixa AIDS Research Institute in Badalona, Spain.


“Our results reveal that HIV-1 infection impacts liver miRNA metabolism and upregulated plasma levels of miRNAs that were previously associated with liver damage, even in the absence of an HCV coinfection,” he said at the Conference on Retroviruses & Opportunistic Infections. He reported the results in a themed discussion and scientific poster session.

Dr. Martinez and his colleagues performed large-scale deep sequencing analyses of miRNAs in plasma from 144 patients with HIV-1 who had elevated alanine aminotransferase (ALT), focal nodular hyperplasia, or HCV coinfections, and compared results with those from healthy blood donors and HCV mono-infected persons.

They identified 1,425 different mature miRNAs in the study samples. Compared with healthy donors, patients with HIV infections showed significantly dysregulated expression of 25 miRNAs, and 19 of these miRNAs were also found in patients with HCV monoinfection. All but 1 of 14 upregulated miRNAs in patients with HCV monoinfections were also upregulated in patients with HIV monoinfections.

Of these 13 upregulated miRNAs, 11 significantly and positively correlated with ALT and aspartate aminotransferase (AST) levels in most of the study samples, including those from healthy donors, Dr. Martinez noted.

“These results indicate that HIV mono-infection is able to dysregulate microRNAs related with liver injury and damage,” he said.

Pages

Recommended Reading

HCV screening, care inadequate for young adults who use opioids nonmedically
MDedge Internal Medicine
Inflammatory markers predict vaccine response in HCV, HIV
MDedge Internal Medicine
Viremic suppression linked to decreased MACE rate in patients with HCV-cirrhosis
MDedge Internal Medicine
ACIP unanimously recommends HEPLISAV-B
MDedge Internal Medicine
HCV infection tied to premature ovarian senescence and a high miscarriage rate
MDedge Internal Medicine
NASH rapidly overtaking hepatitis C as cause of liver cancer
MDedge Internal Medicine
Bioengineered liver models screen drugs and study liver injury
MDedge Internal Medicine
Alcohol dependence may accelerate aging, frontal cortical deficits
MDedge Internal Medicine
HIV+ dialysis patients: Differential survival by race compared with HIV/HCV coinfection
MDedge Internal Medicine
Switching to tenofovir alafenamide may benefit HBV patients
MDedge Internal Medicine